Discontinued — last reported Q4 '25

Financing

Payments For Excise Tax

West Pharmaceutical Services Payments For Excise Tax remained flat by 0.0% to $1.05M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 47.5%, from $2.00M to $1.05M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2025Feb 17, 2026

How to read this metric

An increase may indicate higher tax liabilities related to specific corporate financial maneuvers or regulatory changes.

Detailed definition

This represents cash outflows specifically designated for excise taxes related to financing or corporate activities. It...

Peer comparison

Highly specific to the regulatory environment and tax structure of the company's operating jurisdictions.

Metric ID: financing_payments_for_excise_tax

Historical Data

14 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.00M$1.05M$1.05M$1.05M$1.05M
QoQ Change-47.5%+0.0%+0.0%+0.0%
YoY Change-47.5%
Range$0.00$2.00M
Avg YoY Growth-47.5%
Median YoY Growth-47.5%
Current Streak3 quarters growth

Frequently Asked Questions

What is West Pharmaceutical Services's payments for excise tax?
West Pharmaceutical Services (WST) reported payments for excise tax of $1.05M in Q4 2025.
How has West Pharmaceutical Services's payments for excise tax changed year-over-year?
West Pharmaceutical Services's payments for excise tax decreased by 47.5% year-over-year, from $2.00M to $1.05M.
What does payments for excise tax mean?
Cash paid to cover excise taxes associated with financing activities.